ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,295, issued on April 7, was assigned to TRANSLATE BIO INC. (Waltham, Mass.) and ETHRIS GMBH (Planegg, Germany).
"CFTR mRNA compositions and related methods and uses" was invented by Michael Heartlein (Waltham, Mass.), Braydon Charles Guild (Concord, Mass.), Frank DeRosa (Waltham, Mass.), Carsten Rudolph (Planegg, Germany), Christian Plank (Planegg, Germany) and Lianne Smith (Waltham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Materials, formulations, production methods, and methods for delivery of CFTR mRNA for induction of CFTR expression, including in the mammalian lung are provided. The present invention is particularly useful for treat...